![David Scheer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Scheer
Algemeen Directeur bij Inland Truck Parts Co.
Profiel
David Scheer currently works at Inland Truck Parts Co., as Chief Executive Officer & Director and Revelar Biotherapeutics, Inc., as Director.
Actieve functies van David Scheer
Bedrijven | Functie | Begin |
---|---|---|
Inland Truck Parts Co.
![]() Inland Truck Parts Co. Trucks/Construction/Farm MachineryProducer Manufacturing Inland Truck Parts Co. sells parts for trucks and trailers. It offers air conditioning parts and brake systems, cables and hoses, cases, clutches, differentials, drivelines, electrical parts, engines, power take off - hydraulics parts, pro-guardian parts, springs-suspension-steering parts, transfer cases and transmissions. The firm offers air conditioning, alignments, brake, wheel-end, clutches, electrical, steering, transfer cases and preventative maintanance services. The company was founded in 1944 and is headquartered in Overland Park, KS. | Algemeen Directeur | - |
Revelar Biotherapeutics, Inc.
![]() Revelar Biotherapeutics, Inc. BiotechnologyHealth Technology Revelar Biotherapeutics is a biopharmaceutical company based in Bethesda, MD. Revelar Biotherapeutics, Inc. focuses on developing and commercializing breakthrough therapeutic antibody products to address critical unmet patient needs, particularly in the field of COVID-19 and other therapeutic areas. The company's management team has extensive expertise in clinical development, regulatory affairs, business development, and operations with leading pharmaceutical companies. Revelar was spun out of Twist Bioscience in November 2021 and has the ability to leverage Twist Biopharma's antibody discovery and optimization platform to license additional antibodies for non-COVID targets. The company's therapeutic areas of interest include oncology and infectious diseases. Revelar aims to combine its clinical development and commercialization capabilities with Twist's innovative technology platform and industry and academia collaborations to accelerate the discovery and delivery of transformative antibody therapeutics to meet patients' unmet needs. Revelar was founded by Kevin P. Malobisky, and the CEO is Glenn Marina. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Inland Truck Parts Co.
![]() Inland Truck Parts Co. Trucks/Construction/Farm MachineryProducer Manufacturing Inland Truck Parts Co. sells parts for trucks and trailers. It offers air conditioning parts and brake systems, cables and hoses, cases, clutches, differentials, drivelines, electrical parts, engines, power take off - hydraulics parts, pro-guardian parts, springs-suspension-steering parts, transfer cases and transmissions. The firm offers air conditioning, alignments, brake, wheel-end, clutches, electrical, steering, transfer cases and preventative maintanance services. The company was founded in 1944 and is headquartered in Overland Park, KS. | Producer Manufacturing |
Revelar Biotherapeutics, Inc.
![]() Revelar Biotherapeutics, Inc. BiotechnologyHealth Technology Revelar Biotherapeutics is a biopharmaceutical company based in Bethesda, MD. Revelar Biotherapeutics, Inc. focuses on developing and commercializing breakthrough therapeutic antibody products to address critical unmet patient needs, particularly in the field of COVID-19 and other therapeutic areas. The company's management team has extensive expertise in clinical development, regulatory affairs, business development, and operations with leading pharmaceutical companies. Revelar was spun out of Twist Bioscience in November 2021 and has the ability to leverage Twist Biopharma's antibody discovery and optimization platform to license additional antibodies for non-COVID targets. The company's therapeutic areas of interest include oncology and infectious diseases. Revelar aims to combine its clinical development and commercialization capabilities with Twist's innovative technology platform and industry and academia collaborations to accelerate the discovery and delivery of transformative antibody therapeutics to meet patients' unmet needs. Revelar was founded by Kevin P. Malobisky, and the CEO is Glenn Marina. | Health Technology |